Venture Life Group PLC Cash Flow Conversion Efficiency

Latest as of December 2025: -0.012x

Venture Life Group PLC cash flow conversion efficiency. Based on the latest financial reports, Venture Life Group PLC (VLG) has a cash flow conversion efficiency ratio of -0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-955.00K ≈ $-116.20 USD) by net assets (GBX81.42 Million ≈ $9.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Venture Life Group PLC (2010–2025)

Cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2025. This chart illustrates how Venture Life Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Venture Life Group PLC (VLG) share price today for real-time trading data and today's change.

Venture Life Group PLC Cash Flow Conversion Ratio Explained

Venture Life Group PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Venture Life Group PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Venture Life Group PLC ranked by their cash flow conversion efficiency. Also see VLG company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Global Energy Metals Corp
V:GEMC
-0.028x
Gentlemens Equity S.A.
PA:MLGEQ
N/A
Brave Bison Group PLC
LSE:BBSN
0.021x
Allergy Therapeutics
LSE:AGY
-2.755x
Satis Group S.A.
WAR:STS
0.000x
Maven Income and Growth VCT 4 PLC
LSE:MAV4
-0.007x
Spectra Systems Corp
LSE:SPSY
0.210x
CREATIVEF. G.S.A-K ZY-23
F:19F
0.032x

Annual Cash Flow Conversion Efficiency for Venture Life Group PLC (2010–2025)

The table below shows the annual cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2025. Review how much free cash does Venture Life Group PLC generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX81.42 Million
≈ $9.91K
GBX-264.00K
≈ $-32.12
-0.003x -102.93%
2024-12-31 GBX75.41 Million
≈ $9.18K
GBX8.35 Million
≈ $1.02K
0.111x +2.73%
2023-12-31 GBX76.25 Million
≈ $9.28K
GBX8.22 Million
≈ $1.00K
0.108x +46.53%
2022-12-31 GBX75.66 Million
≈ $9.21K
GBX5.57 Million
≈ $677.22
0.074x +795.58%
2021-12-31 GBX73.16 Million
≈ $8.90K
GBX601.00K
≈ $73.12
0.008x -78.11%
2020-12-31 GBX72.11 Million
≈ $8.77K
GBX2.71 Million
≈ $329.24
0.038x -49.55%
2019-12-31 GBX32.82 Million
≈ $3.99K
GBX2.44 Million
≈ $297.00
0.074x +902.63%
2018-12-31 GBX32.08 Million
≈ $3.90K
GBX238.00K
≈ $28.96
0.007x +225.28%
2017-12-31 GBX14.19 Million
≈ $1.73K
GBX-84.00K
≈ $-10.22
-0.006x +81.40%
2016-12-31 GBX14.36 Million
≈ $1.75K
GBX-457.00K
≈ $-55.60
-0.032x +60.39%
2015-12-31 GBX13.80 Million
≈ $1.68K
GBX-1.11 Million
≈ $-134.93
-0.080x +43.47%
2014-12-31 GBX15.65 Million
≈ $1.90K
GBX-2.22 Million
≈ $-270.60
-0.142x +92.35%
2013-12-31 GBX557.00K
≈ $67.77
GBX-1.03 Million
≈ $-125.93
-1.858x +54.27%
2012-12-31 GBX127.00K
≈ $15.45
GBX-516.00K
≈ $-62.78
-4.063x -164.65%
2011-12-31 GBX312.00K
≈ $37.96
GBX-479.00K
≈ $-58.28
-1.535x -30.19%
2010-12-31 GBX212.00K
≈ $25.79
GBX-250.00K
≈ $-30.42
-1.179x --

About Venture Life Group PLC

LSE:VLG UK Household & Personal Products
Market Cap
$977.42K
GBX8.03 Billion GBX
Market Cap Rank
#30694 Global
#818 in UK
Share Price
GBX67.00
Change (1 day)
-1.47%
52-Week Range
GBX54.25 - GBX71.00
All Time High
GBX114.84
About

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermat… Read more